Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.

  title={Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.},
  author={Anna L Schwartz and Kerri M. Winters-Stone and Betty Bierut Gallucci},
  journal={Oncology nursing forum},
  volume={34 3},
PURPOSE/OBJECTIVES To test the effects of aerobic and resistance exercise on changes in bone mineral density (BMD) in women newly diagnosed with stage I-III breast cancer receiving chemotherapy. DESIGN Randomized clinical trial. SETTING Two National Cancer Institute-designated cancer centers in metropolitan areas. SAMPLE 66 women with stage I-III breast cancer beginning adjuvant chemotherapy. METHODS Participants were randomized to aerobic or resistance exercise and usual care. At the… 

Tables from this paper

Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy.

Zoledronic acid protected patients with breast cancer against bone loss during initial treatment, whereas home-based PA interventions were less effective in preventing bone loss.

A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.

Among women who maintained lean mass, the exercise intervention prevented bone loss; however, the intervention did not prevent bone loss among women who lost muscle mass.

Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial

This 12-month aerobic jumping and circuit training intervention completely prevented femoral neck bone loss in premenopausal breast cancer patients, whereas no effect on BMD was seen in postmenopausal women.

Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy

The dose of the osteogenic stimulus in the intervention has been effective in preserving BMD in healthy postmenopausal women but it may be inadequate for survivors with chemotherapy-induced menopause and for those on adjuvant AI therapy.

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

A 12-month exercise program reversibly prevented hip bone loss in premenopausal women with early breast cancer and maintained femoral neck and total hip aBMD for 3 years, but the protective effect was lost thereafter.

The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis

From the evidence available, exercise may not be sufficient to improve bone health in cancer survivors, but given the heterogeneity in the participant characteristics and several exercise programs which may not have been designed to specifically optimise bone health, these findings should be interpreted with caution.

Exercise for improving bone health in women treated for stages I–III breast cancer: a systematic review and meta-analyses

Exercise alone may not be sufficient to prevent bone loss in post-menopausal women at high risk of osteoporosis, and further studies are needed to confirm whether or not exercise is important in preservation of bone health in women diagnosed with early BC.

The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial

Strength/weight training exercises may prevent loss of BMD in postmenopausal BCS at risk for bone loss.

The Effect on Bone Outcomes of Adding Exercise to Supplements for Osteopenic Breast Cancer Survivors: A Pilot Randomized Controlled Trial

A home-based exercise program for bone health among osteopenic breast cancer survivors is feasible and safe and there was no significant additive effect of exercise on bone outcomes under the conditions studied, however, suggesting the need for a larger trial.

Breast Cancer and Osteoporosis - Management of Cancer Treatment-Induced Bone Loss in Postmenopausal Women with Breast Cancer

Several guidelines have emerged for the management of CTIBL in women with BC, including strategies to identify and treat those at high risk for fractures, and further research on tracking guideline adherence is needed to adjust these guidelines in the future.



Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.

Interventions to prevent BMD loss in women receiving breast cancer treatment including Bisphosphonates are effective, but other interventions such as physical activity and dietary interventions need further testing.

Changes on Bone Mineral Density after Adjuvant Treatment in Women with Non-metastatic Breast Cancer

Women with NMBC are affected by early bone loss after adjuvant chemotherapy, and this bone loss is attenuated by one year of tamoxifen treatment.

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.

  • C. ShapiroJ. ManolaM. LeBoff
  • Medicine, Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2001
Serum osteocalcin and bone specific alkaline phosphatase, markers of skeletal turnover, increased significantly in the women who developed ovarian failure and may have implications for long-term breast cancer survivors who may be at higher risk for osteopenia, and subsequently osteoporosis.

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer.

Oral clodronate appears to reduce the loss of BMD in patients who receive treatment for primary breast cancer, in a double-blind, randomized, two-center trial.

Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes.

Exercise training had beneficial effects on cardiopulmonary function and QOL in postmenopausal breast cancer survivors.

Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.

It is concluded that tamoxifen usage was associated with bone loss in patients who continued to menstruate after adjuvant chemotherapy, and tamoxIFen decreasedBone loss in those women who developed chemotherapy-induced amenorrhea.

Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure

Age at treatment and the total cumulative dose of cyclophosphamide are established predictors of chemotherapy-induced ovarian failure in premenopausal women with breast cancer, but whether other factors including family history of osteoporosis, lifestyle factors, reproductive hormones, bone turnover markers, or bone mineral density of the hip or total spine measured before and 6 months after chemotherapy increased the risk of ovarian failure is sought.

Effects of resistance training on regional and total bone mineral density in premenopausal women: A randomized prospective study

  • T. LohmanS. Going R. Pamenter
  • Medicine
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 1995
The results support the use of strength training for increasing STL and muscular strength with smaller but significant regional increases in BMD in the premenopausal population.

Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial.

High-intensity strength training exercises are an effective and feasible means to preserve bone density while improving muscle mass, strength, and balance in postmenopausal women.

Exercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal women

A low-volume/high-intensity exercise program was successful to maintain bone mineral density at the spine, hip and calcaneus, but not at the forearm over a period of 3 years.